Xtx Topco LTD 9 Meters Biopharma, Inc. Transaction History

Xtx Topco LTD

  • $1.3 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$0.52 - $1.0 $14,116 - $27,147
-27,147 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$0.85 - $1.33 $14,390 - $22,516
16,930 Added 165.7%
27,147 $27,000
Q3 2021

Nov 12, 2021
SELL
$1.03 - $1.41 $10,516 - $14,396
-10,210 Reduced 49.98%
10,217 $13,000
Q2 2021

Aug 12, 2021
BUY
$1.04 - $1.5 $10,048 - $14,493
9,662 Added 89.75%
20,427 $22,000
Q1 2021

May 14, 2021
BUY
$0.84 - $2.16 $9,042 - $23,252
10,765 New
10,765 $13,000

Others Institutions Holding NMTR

# of Institutions
3
Shares Held
67.9K
Call Options Held
0
Put Options Held
0
View Full List

About 9 METERS BIOPHARMA, INC.

NMTR Quotes by TradingView
  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email